Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
6.22M
-
Shares change
-
+889K
-
Total reported value, excl. options
-
$6.07M
-
Value change
-
+$589K
-
Put/Call ratio
-
1
-
Number of buys
-
9
-
Number of sells
-
-13
-
Price
-
$0.98
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2021
38 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q4 2021.
IGC Pharma, Inc. - COM NEW (IGC) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.22M shares
.
Largest 10 shareholders include Mirae Asset Global Investments Co., Ltd. (1.66M shares), Davy Global Fund Management Ltd (1.58M shares), BlackRock Inc. (861K shares), VANGUARD GROUP INC (655K shares), GEODE CAPITAL MANAGEMENT, LLC (292K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (288K shares), STATE STREET CORP (170K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (139K shares), DEARBORN PARTNERS LLC (96.9K shares), and BANK OF AMERICA CORP /DE/ (90.3K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.